Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli.
about
Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyondParallel Mapping of Antibiotic Resistance Alleles in Escherichia coliThe Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex BacteriaEradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacinAntibiotics induce redox-related physiological alterations as part of their lethality.Identification and evaluation of the role of the manganese efflux protein in Deinococcus radioduransResistance to topoisomerase cleavage complex induced lethality in Escherichia coli via titration of transcription regulators PurR and FNR.Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics.Reactive oxygen species and the bacterial response to lethal stressAntifungal activity of redox-active benzaldehydes that target cellular antioxidation.Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa.Transfer RNAs Mediate the Rapid Adaptation of Escherichia coli to Oxidative Stress.Atmospheric Nonthermal Plasma-Treated PBS Inactivates Escherichia coli by Oxidative DNA Damage.Resveratrol Antagonizes Antimicrobial Lethality and Stimulates Recovery of Bacterial Mutants.Bactericidal antibiotics do not appear to cause oxidative stress in Listeria monocytogenesInvolvement of multiple stressors induced by non-thermal plasma-charged aerosols during inactivation of airborne bacteria.Bactericidal Antibiotics Induce Toxic Metabolic Perturbations that Lead to Cellular DamageMycobacterium fluoroquinolone resistance protein B, a novel small GTPase, is involved in the regulation of DNA gyrase and drug resistance.Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents.Cell death from antibiotics without the involvement of reactive oxygen speciesA dysfunctional tricarboxylic acid cycle enhances fitness of Staphylococcus epidermidis during β-lactam stress.Bacterial topoisomerase I as a target for discovery of antibacterial compounds.Dimethyl Sulfoxide Protects Escherichia coli from Rapid Antimicrobial-Mediated KillingEvidence for Direct Control of Virulence and Defense Gene Circuits by the Pseudomonas aeruginosa Quorum Sensing Regulator, MvfRHydroxyl radicals are involved in cell killing by the bacterial topoisomerase I cleavage complex.De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.Production of Superoxide in Bacteria Is Stress- and Cell State-Dependent: A Gating-Optimized Flow Cytometry Method that Minimizes ROS Measurement Artifacts with Fluorescent Dyes.Bacterial stress responses as determinants of antimicrobial resistance.In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia.The stringent response controls catalases in Pseudomonas aeruginosa and is required for hydrogen peroxide and antibiotic tolerance.Efficacy of Compound Therapy by Ginseng and Ciprofloxacin on Bacterial Prostatitis.Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhimurium and Salmonella typhi.High-level iron mitigates fusaricidin-induced membrane damage and reduces membrane fluidity leading to enhanced drug resistance in Bacillus subtilis.l-Serine potentiates fluoroquinolone activity against Escherichia coli by enhancing endogenous reactive oxygen species production.Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors.Mutational Consequences of Ciprofloxacin in Escherichia coliIn Vitro Anti-inflammatory and Immunomodulatory Effects of Ciprofloxacin or Azithromycin in Staphylococcus aureus-Stimulated Murine Macrophages are Beneficial in the Presence of Cytochalasin D.Superoxide protects Escherichia coli from bleomycin mediated lethalityContribution of oxidative damage to antimicrobial lethality.Involvement of Antibiotic Efflux Machinery in Glutathione-Mediated Decreased Ciprofloxacin Activity in Escherichia coli
P2860
Q27001203-C6D8CBA4-38B2-43F9-9637-A66160DD7F32Q28552559-CB3E2F0D-F739-407E-8C4C-70961B211F1FQ28552750-E83D5848-EADA-43ED-B746-5CB3B920CF9AQ33357682-9369ED8F-EA68-4E11-9C43-9E8F007B4CD2Q33665248-DB7C3B8D-6462-4499-9384-34B7A32479A5Q33771174-4BCC94B5-2B0A-4CAD-961F-EAE1225C10B0Q34094698-EF0EEE4D-CEC9-4A75-94F1-53BF3F9F006BQ34309407-8758A7F1-15D2-46AA-8541-3F65428F311BQ34624207-722DF160-603D-490D-96C2-517BFE548400Q35081105-0037F555-4413-4EE1-A813-7F233A58B764Q35667778-A5554987-03C6-406B-A028-0AF3C58773C9Q35668292-117D2D0C-96A9-41F9-9B0C-7CBD7CCCF0D9Q35804670-512BBFA7-9D2F-4DF0-A651-7070CBC812A5Q35979673-C9AF379E-A8BF-4EB9-8928-FBDB0CAAA021Q36017982-98E763D8-18CF-4A74-8069-3574E5912EE6Q36271589-66F2C66D-A6DE-43C7-8242-6A65D40DA907Q36289433-598E8CE6-74ED-4305-95D2-68A1DBE2CD3AQ36619820-536BDC2B-0C1D-4DEB-8007-65F9D3F69E1CQ36735435-F315BC87-AD5C-4BFA-B28D-1CAB22D376B3Q37065875-D234CFAD-232E-4C08-B148-045DCF1A2D3CQ37105664-89CECBD1-1B4C-4328-8620-3C5FE01C30E8Q37108422-C814D9FD-2F4C-4A5F-B4FD-0A196A884EF9Q37120114-C5EA3479-F421-4F07-BB32-FB7114EA25CFQ37291373-28566280-C46F-4505-A277-020D18BD718FQ37302031-BC80672C-AFC9-4D48-ACB4-019735461173Q37612996-B559D7E4-2F5B-4093-8F36-70DC422CF942Q37712651-41FB4B16-7504-47EA-AE56-647A3758E5E3Q38012391-F3E9684E-9B4E-45D7-A8EE-F983A016CE92Q38426420-66D7B115-B9F8-4B51-A948-DAE106CCBD44Q39798896-9845C3C3-4FE5-49EA-9AD9-A56235CE714CQ39831880-3CCA71C5-3EED-44FB-8BC9-BFD973815E4FQ40271196-72EBBF96-D745-44E8-B19C-CC8C1E8BA5CDQ40431847-132EBF95-CF42-4239-BFA9-1F539C6C9077Q40697356-A626B9E1-2D3E-4A1E-9A79-7DF060870BCDQ40878325-E5EDC64B-2B64-44FC-8A05-9EF59BD26D83Q41194789-BCA769CC-8280-4025-8F94-7D161F1EF8DFQ41645682-1BC64A7A-0A23-462E-B784-B2CD642A53FCQ41772060-3D1A2F70-F736-4CF1-8D7E-313F70D89A8BQ41808795-FC5AF442-B8FA-43E2-A122-1ACFEEBA2727Q41851094-D5FBF74A-CD77-43B3-AB06-FD4D9CE0D20D
P2860
Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Involvement of reactive oxygen ...... acin against Escherichia coli.
@ast
Involvement of reactive oxygen ...... acin against Escherichia coli.
@en
Involvement of reactive oxygen ...... acin against Escherichia coli.
@nl
type
label
Involvement of reactive oxygen ...... acin against Escherichia coli.
@ast
Involvement of reactive oxygen ...... acin against Escherichia coli.
@en
Involvement of reactive oxygen ...... acin against Escherichia coli.
@nl
prefLabel
Involvement of reactive oxygen ...... acin against Escherichia coli.
@ast
Involvement of reactive oxygen ...... acin against Escherichia coli.
@en
Involvement of reactive oxygen ...... acin against Escherichia coli.
@nl
P2093
P2860
P1476
Involvement of reactive oxygen ...... acin against Escherichia coli.
@en
P2093
P2860
P304
P356
10.1128/AAC.50.3.949-954.2006
P407
P577
2006-03-01T00:00:00Z